Literature DB >> 11392241

[Limits to arterial embolization treatment of severe postpartum hemorrhage].

P Vandelet1, R Gillet, S Pease, E Clavier, G Descargues, B Dureuil.   

Abstract

OBJECTIVE: To assess the limits of arterial embolization in the management of serious postpartum haemorrhage (PPH). STUDY
DESIGN: Retrospective study. PATIENTS AND METHODS: We examined the cases of 29 patients admitted to intensive care units of Rouen University Hospital for PPH between January 1994 and August 1999. Demographic, obstetrical and biological data, the required treatment and eventual side effects were collected and analysed using the appropriate parametric and non parametric tests.
RESULTS: Arterial embolization was carried out on 15 patients (52%) with a success rate of 73%. Of the 14 other patients, 11 underwent conservative or radical surgery without further complications, three received medical treatment. No maternal death occurred; however, one patient transferred from a local hospital and already presenting haemodynamic instability suffered cardiac arrest before embolization. Arterial embolization was unsuccessful in four cases, two of which were cases of placenta accreta. These patients were older (p < 0.05) and all had a past history of curettage and/or caesarean section for preceding deliveries (p < 0.01).
CONCLUSIONS: Emergency arterial embolization is a valuable therapy in case of PPH but can only be carried out in specialised units. Obstetrical antecedents would appear to constitute a major risk factor and transfer increases the morbidity rate.

Entities:  

Mesh:

Year:  2001        PMID: 11392241     DOI: 10.1016/s0750-7658(01)00386-0

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  1 in total

1.  [Severe hemorrhage in the peripartum in intensive care unit in a level 3 Tunisian university center: epidemiology and risk factors for maternal mortality].

Authors:  Laidi Ben Nasr; Sofiene Ben Marzouk; Mehdi Kehila; Hamed Jabri; Saber Thamleoui; Hayen Maghrebi
Journal:  Pan Afr Med J       Date:  2015-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.